Does the ERBB/EGF Signaling Network Serve as a Nexus for Oncogenic Signals in Uveal Melanoma?
Biomolecules · 23.07.2026 · 16 (8) · 1079
DOI: 10.3390/biom16081079 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 23.07.2026. Verfasst von Niusha Raeesian und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA. Hauptthemen laut MEDLINE: Uveal Neoplasms, Melanoma, Signal Transduction, Epidermal Growth Factor. Die Arbeit nennt 280 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, United States National Institutes of Health.
Abstract (Originalsprache)
Uveal melanomas (UMs) metastasize at a high frequency, and metastatic UMs are associated with very poor clinical outcomes. Consequently, there is considerable interest in the genetics and biochemistry of UM and in how these insights may lead to novel and effective approaches to treating it. This work reviews the biology and pharmacotherapy of UM. It also summarizes signaling by the network comprising ERBB receptor tyrosine kinases and EGF family peptide growth factors, including mechanisms of crosstalk with G protein-coupled receptors. Next, this work discusses signaling changes that appear to drive UM, particularly increased signaling by the CYSLTR2/Gαq/Gα11 pathway. Finally, this work suggests that some of the signaling events that drive UM may be the consequence of crosstalk between the CYSLTR2/Gαq/Gα11 pathway and the ERBB/EGF signaling network. Thus, this work proposes that the ERBB/EGF signaling network may be a novel therapeutic target for UM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.
- Program in Molecular Biotechnology, Department of Applied Biosciences and Process Engineering, Anhalt University of Applied Sciences, 06366 Köthen, Germany.
- Cancer Biology and Immunology Research Program, O'Neal Comprehensive Cancer Center, Heersink College of Medicine, University of Alabama-Birmingham, Birmingham, AL 35233, USA.
ORCID-Profile: David J Riese
Förderung
- NCI NIH HHS
- NIH HHS
- United States National Institutes of Health
Zitieren
APA
Raeesian, N., & Riese, D. J. (2026). Does the ERBB/EGF Signaling Network Serve as a Nexus for Oncogenic Signals in Uveal Melanoma?. Biomolecules, 16(8), 1079. https://doi.org/10.3390/biom16081079
Vancouver
Raeesian N, Riese DJ. Does the ERBB/EGF Signaling Network Serve as a Nexus for Oncogenic Signals in Uveal Melanoma?. Biomolecules. 2026;16(8):1079. doi:10.3390/biom16081079
BibTeX
@article{Raeesian2026,
author = {Raeesian, Niusha and Riese, David J},
title = {Does the ERBB/EGF Signaling Network Serve as a Nexus for Oncogenic Signals in Uveal Melanoma?},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {8},
pages = {1079},
doi = {10.3390/biom16081079}
}
EUVIMED